147 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1955. These forward-looking statements include, without limitation
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform
8-K/A
EX-99.1
eb6wglmj j4
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
5:23pm
8-K
yxhvx
27 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:35am
8-K
EX-99.1
khdgkl2blntpez1wb
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
8:32am
424B3
61m nd93yb7h
5 Mar 24
Prospectus supplement
5:08pm
424B3
zb5ab4d uzgeef2
5 Mar 24
Prospectus supplement
5:06pm
424B3
n60t00kjzhyeoohnyq4
5 Mar 24
Prospectus supplement
5:04pm
424B3
gh8 fmehw1
5 Mar 24
Prospectus supplement
4:59pm
424B3
i32 faspt6rz5zm5uym
5 Mar 24
Prospectus supplement
4:57pm
424B3
bvftsx p32w
5 Mar 24
Prospectus supplement
4:56pm
8-K
EX-99.1
zjv15jvkbg8
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
424B5
carn4v6wkivnec
30 Jan 24
Prospectus supplement for primary offering
10:55am
8-K
EX-10.1
khbzbmgyusrlc laenz
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
brhs9 uu4k3n55ijq
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am